Following shareholder approval on Friday, 9 June 2023, the acquisition became effective on Thursday, 6 July 2023 and Medica has now been de-listed from the London Stock Exchange.
Founded in 2004 and headquartered in Hastings, UK, Medica is a leading healthcare services provider with operations in the UK, Ireland and US. With over 400 employees globally, Medica has a network of more than 750 radiologists, radiographers and specialist doctors who serve over 200 clients worldwide. In the UK and Ireland, Medica provides a fast and reliable reporting service (including out-of-hours) for MRI, CT, Ultrasound and X-Ray to more than 100 National Health Service trusts, the Irish Health Service Executive and independent sector organisations. Through its subsidiary in the US, RadMD, Medica provides high-quality imaging services for clinical trials within the pharmaceuticals, biotechnology and medical device industries, with particular expertise in oncology. Within the area of clinical trials, Medica has, to date, contributed to over 600 studies globally.
The Travers Smith team was led by Partners Emma Havas, Richard Spedding and Ben Lowen, supported by Associates Niki Jeropoulos and China Waters, and trainee Matthew Hoyle. The team also included Incentives & Remuneration support from Senior Counsel Elissavet Grout and Senior Associate Claire Prentice, and Tax support from Partner Simon Skinner, Senior Associates Silvana Van der Velde and Kyle Rainsford.
